BioSpace News Archive

GeoVax Labs, Inc. announced that members of its senior management team and other scientific representatives will participate in four upcoming investor and industry events during November.

ReHeva Biosciences, a pioneering biopharmaceutical startup with the mission to help people live longer and healthier with cancer through naturally derived complex drugs, proudly announces the successful completion of its Phase I Safety Trial for its novel drug, RH324.

Medeor Therapeutics announced that it will present interim Phase 3 data investigating if MDR-101 cell therapy can safely induce immune tolerance and eliminate the need for immunosuppressive drugs vs. standard of care following a kidney transplant as a late-breaking oral presentation at the American Society of Nephrology Kidney Week, November 1-5, 2023 in Philadelphia, Pennsylvania.

Carisma Therapeutics Inc. today announced that new pre-clinical data leveraging an mRNA platform to develop in-vivo chimeric antigen receptor macrophage (“CAR-M”) will be presented as a late-breaking abstract (#LBA1514) at the upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting held from Wednesday, November 1, to Sunday, November 5, 2023, in San Diego, California.

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, and FibroFighters, a patient-centric advocacy and education organization dedicated to helping patients and caregivers affected by Fibrolamellar Carcinoma, have announced a collaboration to advance clinical care for FLC patients.

Secarna Pharmaceuticals GmbH & Co. KG (“Secarna”), a biopharmaceutical company focusing on the discovery and development of next-generation antisense oligonucleotide (ASO) therapies to address challenging or previously undruggable targets via its LNAplus platform, has presented data showing the potential as well as the versatility of Secarna’s LNA-modified ASOs.

Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in cell therapy to treat cancer, will report financial results and provide business updates for the third quarter ended September 30, 2023, before the US markets open on Wednesday, November 8, 2023

PENTAX Medical America Inc., a division of HOYA Group, has launched two of its latest innovations: the PENTAX Medical INSPIRA™, a premier 4K video processor, and the i20c video endoscope series.

Cadence Molecular Sciences announced that Pfizer Inc. has signed an agreement to extend and expand access to Cadence® products and programming toolkits for advanced molecular design.

HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence heart care solutions, announced results from three clinical studies supporting the use of advanced coronary computed tomography angiography -based technologies in the assessment of patients with suspected coronary artery disease.